Explore
Validate
Learn13820-1-AP
antibody from Proteintech Group
Targeting: RCHY1
ARNIP, CHIMP, DKFZp586C1620, PIRH2, PRO1996, RNF199, ZCHY, ZNF363
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13820-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Pirh2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated Pirh2 antibody (Cat. #13820-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references G6PD-mediated increase in de novo NADP(+) biosynthesis promotes antioxidant defense and tumor metastasis.
Genomic gain of RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling.
Avenanthramide A Induces Cellular Senescence via miR-129-3p/Pirh2/p53 Signaling Pathway To Suppress Colon Cancer Growth.
Zhang Y, Xu Y, Lu W, Li J, Yu S, Brown EJ, Stanger BZ, Rabinowitz JD, Yang X
Science advances 2022 Jul 22;8(29):eabo0404
Science advances 2022 Jul 22;8(29):eabo0404
Genomic gain of RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling.
Cao P, Yang A, Li P, Xia X, Han Y, Zhou G, Wang R, Yang F, Li Y, Zhang Y, Cui Y, Ji H, Lu L, He F, Zhou G
Science advances 2021 Aug;7(35)
Science advances 2021 Aug;7(35)
Avenanthramide A Induces Cellular Senescence via miR-129-3p/Pirh2/p53 Signaling Pathway To Suppress Colon Cancer Growth.
Fu R, Yang P, Sajid A, Li Z
Journal of agricultural and food chemistry 2019 May 1;67(17):4808-4816
Journal of agricultural and food chemistry 2019 May 1;67(17):4808-4816
No comments: Submit comment
No validations: Submit validation data